RecruitingNCT05706558

Retrospective Review of Esophageal Cancer at MSKCC

Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

4,000 participants

Start Date

Dec 13, 2016

Study Type

OBSERVATIONAL

Conditions

Esophageal Cancer Esophagus Cancer

Summary

Residual tumor at the proximal or distal margin after esophagectomy is a known prognostic factor for poor survival outcomes in patients with esophageal cancer; however, the significance of the circumferential resection margin (CRM) remains controversial. In this study, the investigators sought to evaluate the prognostic significance of the CRM in patients with esophageal cancer undergoing resection.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a retrospective study (looking back at existing medical records) at Memorial Sloan Kettering Cancer Center to analyze data from patients who had surgery to remove esophageal cancer (esophagectomy) with tumors that had grown through the esophageal wall (Stage T3). **You may be eligible if...** - You have had an esophagectomy (surgical removal of part of the esophagus) - Your esophageal cancer was confirmed as adenocarcinoma or squamous cell carcinoma - Your tumor was staged as pT3 (the tumor grew through the wall of the esophagus but did not reach neighboring organs) **You may NOT be eligible if...** - Your tumor was a different stage (T0, T1, T2, or T4) - Your cancer was a type other than adenocarcinoma or squamous cell carcinoma - You had a salvage surgery after failed prior treatment - Your cancer had spread to distant sites - Your surgical margins were not clear (cancer at the cut edges) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.